Source: FinanzNachrichten

Lexaria Bioscience: Lexaria Bioscience Corp.: Lexaria Releases Annual Letter from the CEO

KELOWNA, BC / ACCESSWIRE / January 13, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide...

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Chris Bunka's photo - Chairman & CEO of Lexaria Bioscience

Chairman & CEO

Chris Bunka

CEO Approval Rating

74/100

Read more